These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26235178)

  • 41. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII.
    D'Ascenzio M; Carradori S; De Monte C; Secci D; Ceruso M; Supuran CT
    Bioorg Med Chem; 2014 Mar; 22(6):1821-31. PubMed ID: 24560739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX.
    Hulikova A; Zatovicova M; Svastova E; Ditte P; Brasseur R; Kettmann R; Supuran CT; Kopacek J; Pastorek J; Pastorekova S
    FEBS Lett; 2009 Nov; 583(22):3563-8. PubMed ID: 19861127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of small molecule carbonic anhydrase IX inhibitors.
    Supuran CT
    BJU Int; 2008 Jun; 101 Suppl 4():39-40. PubMed ID: 18430122
    [No Abstract]   [Full Text] [Related]  

  • 44. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
    Robertson N; Potter C; Harris AL
    Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts.
    Gieling RG; Babur M; Mamnani L; Burrows N; Telfer BA; Carta F; Winum JY; Scozzafava A; Supuran CT; Williams KJ
    J Med Chem; 2012 Jun; 55(11):5591-600. PubMed ID: 22621623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy.
    Kivelä AJ; Knuuttila A; Räsänen J; Sihvo E; Salmenkivi K; Saarnio J; Pastorekova S; Pastorek J; Waheed A; Sly WS; Salo JA; Parkkila S
    Bioorg Med Chem; 2013 Mar; 21(6):1483-8. PubMed ID: 23036334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
    Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C
    Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbonic anhydrase inhibitors: benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII.
    Alafeefy AM; Isik S; Abdel-Aziz HA; Ashour AE; Vullo D; Al-Jaber NA; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1396-403. PubMed ID: 23290254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides.
    Baranauskienė L; Hilvo M; Matulienė J; Golovenko D; Manakova E; Dudutienė V; Michailovienė V; Torresan J; Jachno J; Parkkila S; Maresca A; Supuran CT; Gražulis S; Matulis D
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):863-70. PubMed ID: 20166809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a
    Shin UC; Choi JS; Beak YJ; Lee MW; Kim HS; Choi DW; Kim DG; Kim SW
    J Labelled Comp Radiopharm; 2021 Mar; 64(3):129-139. PubMed ID: 33119930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
    Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
    Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
    Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.
    Rami M; Maresca A; Smaine FZ; Montero JL; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2011 May; 21(10):2975-9. PubMed ID: 21470859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.
    Hedley D; Pintilie M; Woo J; Morrison A; Birle D; Fyles A; Milosevic M; Hill R
    Clin Cancer Res; 2003 Nov; 9(15):5666-74. PubMed ID: 14654550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of carbonic anhydrase IX in craniopharyngiomas.
    Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A
    J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbonic anhydrase IX as a target for metastatic disease.
    Gieling RG; Williams KJ
    Bioorg Med Chem; 2013 Mar; 21(6):1470-6. PubMed ID: 23098607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
    Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.